Vcanbio Cell & Gene Engineering Corp Ltd (600645) — Capital Reinvestment Ratio
Vcanbio Cell & Gene Engineering Corp Ltd (600645) has a Capital Reinvestment Ratio of 0.13x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥103.70 Million) in capital expenditures (CN¥13.28 Million). Check Vcanbio Cell & Gene Engineering Corp Ltd (600645) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Vcanbio Cell & Gene Engineering Corp Ltd Capital Reinvestment Ratio (1999–2025)
This chart tracks Vcanbio Cell & Gene Engineering Corp Ltd's Capital Reinvestment Ratio across 25 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Vcanbio Cell & Gene Engineering Corp Ltd.
Annual Capital Reinvestment Ratio for Vcanbio Cell & Gene Engineering Corp Ltd (1999–2025)
Year-by-year Capital Reinvestment Ratio for Vcanbio Cell & Gene Engineering Corp Ltd from 1999 to 2025. See Vcanbio Cell & Gene Engineering Corp Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | CN¥313.63 Million | CN¥49.56 Million | ▼ -33.1% |
| 2024 | 0.24x | CN¥285.19 Million | CN¥67.32 Million | ▼ -20.3% |
| 2023 | 0.30x | CN¥299.02 Million | CN¥88.61 Million | ▼ -21.8% |
| 2022 | 0.38x | CN¥261.89 Million | CN¥99.19 Million | ▼ -4.8% |
| 2021 | 0.40x | CN¥320.96 Million | CN¥127.74 Million | ▲ +6.0% |
| 2020 | 0.38x | CN¥244.35 Million | CN¥91.72 Million | ▼ -26.3% |
| 2019 | 0.51x | CN¥241.49 Million | CN¥122.95 Million | ▼ -48.3% |
| 2018 | 0.99x | CN¥130.08 Million | CN¥128.13 Million | ▼ -16.6% |
| 2017 | 1.18x | CN¥70.27 Million | CN¥83.02 Million | ▼ -37.1% |
| 2016 | 1.88x | CN¥143.67 Million | CN¥269.85 Million | ▼ -88.1% |
| 2015 | 15.74x | CN¥8.17 Million | CN¥128.70 Million | ▲ +5665.4% |
| 2014 | 0.27x | CN¥221.45 Million | CN¥60.47 Million | ▼ -57.1% |
| 2013 | 0.64x | CN¥110.72 Million | CN¥70.43 Million | ▼ -19.4% |
| 2012 | 0.79x | CN¥70.41 Million | CN¥55.56 Million | ▲ +488.4% |
| 2011 | 0.13x | CN¥110.44 Million | CN¥14.81 Million | ▲ +352.1% |
| 2010 | 0.03x | CN¥175.93 Million | CN¥5.22 Million | ▼ -78.6% |
| 2009 | 0.14x | CN¥124.92 Million | CN¥17.32 Million | ▼ -17.0% |
| 2008 | 0.17x | CN¥121.60 Million | CN¥20.32 Million | ▲ +4.1% |
| 2007 | 0.16x | CN¥111.68 Million | CN¥17.92 Million | ▼ -74.4% |
| 2006 | 0.63x | CN¥76.12 Million | CN¥47.67 Million | ▼ -7.8% |
| 2005 | 0.68x | CN¥84.69 Million | CN¥57.55 Million | ▲ +44.2% |
| 2004 | 0.47x | CN¥57.76 Million | CN¥27.23 Million | ▼ -45.5% |
| 2003 | 0.86x | CN¥41.74 Million | CN¥36.08 Million | ▲ +219.3% |
| 2000 | 0.27x | CN¥31.71 Million | CN¥8.58 Million | ▼ -87.2% |
| 1999 | 2.12x | CN¥4.13 Million | CN¥8.76 Million | — |